PDF) Therapeutic siRNA: State-of-the-Art and Future Perspectives
Abteilung Klinische Pharmakologie
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Curriculum vitae
Loop | Achim Aigner
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence | Oncogenesis
Business-Academic Team to Create RNA Delivery for Cancer « Science and Enterprise
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library
Pharmaceutics & Novel Drug Delivery Systems
Mitarbeiter des Rudolf-Boehm-Institutes
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Cancers | Free Full-Text | Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim Aigner: H-index & Awards - Academic Profile | Research.com
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer - SiSaf Ltd
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma
Mitarbeiter des Rudolf-Boehm-Institutes
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma
PDF) Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma 1 2
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
